EAT: A Reliable Eating Assessment Technology for Free-living Individuals

NCT ID: NCT06118528

Last Updated: 2024-10-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-04

Study Completion Date

2025-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study utilizes a small, privacy-conscious wearable device intended to monitor human behaviors. The device is worn around the neck, capturing the wearer's head and upper torso within its field of view, and records color images without audio. Participants visit the lab for consent, device training and recording of several activities using the device. Participants will then take the device home and wear it during their normal schedules for four "active" weeks. During each active week, participants will wear the device, keep a log of all food and drink items consumed throughout the day and participate in unscheduled phone calls with a dietitian. A "washout" week occurs in between each active week in which participants do not need to complete any study tasks. Alongside the device, we have included three privacy filters (blur, edge, and avatar) capable of obscuring faces and objects seen in the device-captured images. All participants will be subject to unfiltered recording during their first week followed by a different filter each following active week in a random order. At the start of each active week, participants view an example of what their recorded images will look like that week (given the privacy filter). At the end of the seven weeks, participants will return the device and provide the lab with feedback on the design of the device and its privacy-preserving features.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wearable Electronic Device

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Blur Obfuscation

Group Type EXPERIMENTAL

Blur Obfuscation

Intervention Type DEVICE

Blurring is applied to the RGB images.

Edge Obfuscation

Group Type EXPERIMENTAL

Edge Obfuscation

Intervention Type DEVICE

A black background and simple outlines of objects/people are applied to the RGB images.

Cartoon Obfuscation

Group Type EXPERIMENTAL

Cartoon Obfuscation

Intervention Type DEVICE

Cartoonization is applied to the RGB images.

No Obfuscation (Raw)

Group Type EXPERIMENTAL

No Obfuscation (raw)

Intervention Type DEVICE

No editing is performed on the RGB images.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blur Obfuscation

Blurring is applied to the RGB images.

Intervention Type DEVICE

Cartoon Obfuscation

Cartoonization is applied to the RGB images.

Intervention Type DEVICE

Edge Obfuscation

A black background and simple outlines of objects/people are applied to the RGB images.

Intervention Type DEVICE

No Obfuscation (raw)

No editing is performed on the RGB images.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI greater than or equal to 18.5
* Chicago metropolitan area resident
* Able to speak, read and write in English
* Has a valid phone number
* Owns a smartphone
* Has access to a computer

Exclusion Criteria

* Pregnant or breastfeeding individuals
* Experienced significant weight loss/gain in the last three months (25 lbs or more)
* Diagnosed with or has a family history of genetic obesity syndromes (e.g., Prader-Willi, Bardet-Biedl, Cohen Syndrome)
* Member of household enrolled in the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

Sponsor Role collaborator

Northwestern University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Northwestern University

Chicago, Illinois, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nabil Alshurafa

Role: CONTACT

3125034517

Bonnie Nolan

Role: CONTACT

3125031216

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nabil Alshurafa, PhD

Role: primary

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01DK129843-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

STU00215714

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prevention of Weight Gain
NCT00011102 COMPLETED NA
Text Messaging for Weight Loss
NCT02063048 COMPLETED NA